Marshall Wace, LLP Emergent Bio Solutions Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 309,472 shares of EBS stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
309,472
Previous 78,178
295.86%
Holding current value
$2.45 Million
Previous $187,000
318.18%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EBS
# of Institutions
137Shares Held
35.6MCall Options Held
78.7KPut Options Held
75.1K-
Black Rock Inc. New York, NY7.06MShares$56 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.15MShares$32.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$27.1 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.91MShares$15.1 Million0.19% of portfolio
-
Morgan Stanley New York, NY1.29MShares$10.3 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $395M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...